264 related articles for article (PubMed ID: 33034026)
1. NOTCH and Esophageal Squamous Cell Carcinoma.
Li Y; Li Y; Chen X
Adv Exp Med Biol; 2021; 1287():59-68. PubMed ID: 33034026
[TBL] [Abstract][Full Text] [Related]
2. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
[TBL] [Abstract][Full Text] [Related]
3. The notch pathway is activated in neoplastic progression in esophageal squamous cell carcinoma.
Lubin DJ; Mick R; Shroff SG; Stashek K; Furth EE
Hum Pathol; 2018 Feb; 72():66-70. PubMed ID: 29137934
[TBL] [Abstract][Full Text] [Related]
4. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
Forghanifard MM; Kasebi P; Abbaszadegan MR
Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
[TBL] [Abstract][Full Text] [Related]
6. Alcohol drinking inhibits NOTCH-PAX9 signaling in esophageal squamous epithelial cells.
Shi M; Ren S; Chen H; Li J; Huang C; Li Y; Han Y; Li Y; Sun Z; Chen X; Xiong Z
J Pathol; 2021 Apr; 253(4):384-395. PubMed ID: 33314197
[TBL] [Abstract][Full Text] [Related]
7. Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis.
Forghanifard MM; Taleb S; Abbaszadegan MR
Pathol Oncol Res; 2015 Apr; 21(2):463-7. PubMed ID: 25361534
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-23 receptor signaling mediates cancer dormancy and radioresistance in human esophageal squamous carcinoma cells via the Wnt/Notch pathway.
Zhou Y; Su Y; Zhu H; Wang X; Li X; Dai C; Xu C; Zheng T; Mao C; Chen D
J Mol Med (Berl); 2019 Feb; 97(2):177-188. PubMed ID: 30483821
[TBL] [Abstract][Full Text] [Related]
9. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.
Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M
Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417
[TBL] [Abstract][Full Text] [Related]
10. Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool.
Huang H; Jiang Y; Liu J; Luo D; Yuan J; Mu R; Yu X; Sun D; Lin J; Chen Q; Li X; Jiang M; Xu J; Chu B; Yin C; Zhang L; Ye Y; Cao B; Wang Q; Zhang Y
Nat Commun; 2024 May; 15(1):4124. PubMed ID: 38750026
[TBL] [Abstract][Full Text] [Related]
11. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
[TBL] [Abstract][Full Text] [Related]
12. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
13. FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.
Lu Z; Ren Y; Zhang M; Fan T; Wang Y; Zhao Q; Liu HM; Zhao W; Hou G
Biomed Pharmacother; 2018 Nov; 107():1370-1376. PubMed ID: 30257352
[TBL] [Abstract][Full Text] [Related]
14. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
Wang C; Cheng L; Song S; Wu S; Sun G
J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
[TBL] [Abstract][Full Text] [Related]
15. Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.
Munemoto M; Mukaisho KI; Miyashita T; Oyama K; Haba Y; Okamoto K; Kinoshita J; Ninomiya I; Fushida S; Taniura N; Sugihara H; Fujimura T
Cancer Sci; 2019 Aug; 110(8):2408-2420. PubMed ID: 31215094
[TBL] [Abstract][Full Text] [Related]
16. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
Chen Q; Hou J; Wu Z; Zhao J; Ma D
Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
18. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
19. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway.
Wang Y; Yu XJ; Zhou W; Chu YX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
